Eintrag weiter verarbeiten
Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo
Gespeichert in:
| Zeitschriftentitel: | Therapeutic Advances in Drug Safety |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , |
| In: | Therapeutic Advances in Drug Safety, 10, 2019, S. 204209861986485 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
SAGE Publications
|
| Schlagwörter: |
| author_facet |
Nzolo, Didier Kuemmerle, Andrea Lula, Yves Ntamabyaliro, Nsengi Engo, Aline Mvete, Bibiche Liwono, Jerry Lusakibanza, Mariano Mesia, Gauthier Burri, Christian Mampunza, Samuel Tona, Gaston Nzolo, Didier Kuemmerle, Andrea Lula, Yves Ntamabyaliro, Nsengi Engo, Aline Mvete, Bibiche Liwono, Jerry Lusakibanza, Mariano Mesia, Gauthier Burri, Christian Mampunza, Samuel Tona, Gaston |
|---|---|
| author |
Nzolo, Didier Kuemmerle, Andrea Lula, Yves Ntamabyaliro, Nsengi Engo, Aline Mvete, Bibiche Liwono, Jerry Lusakibanza, Mariano Mesia, Gauthier Burri, Christian Mampunza, Samuel Tona, Gaston |
| spellingShingle |
Nzolo, Didier Kuemmerle, Andrea Lula, Yves Ntamabyaliro, Nsengi Engo, Aline Mvete, Bibiche Liwono, Jerry Lusakibanza, Mariano Mesia, Gauthier Burri, Christian Mampunza, Samuel Tona, Gaston Therapeutic Advances in Drug Safety Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo Pharmacology (medical) |
| author_sort |
nzolo, didier |
| spelling |
Nzolo, Didier Kuemmerle, Andrea Lula, Yves Ntamabyaliro, Nsengi Engo, Aline Mvete, Bibiche Liwono, Jerry Lusakibanza, Mariano Mesia, Gauthier Burri, Christian Mampunza, Samuel Tona, Gaston 2042-0986 2042-0994 SAGE Publications Pharmacology (medical) http://dx.doi.org/10.1177/2042098619864853 <jats:p> Implementation of pharmacovigilance (PV) systems in resource-limited countries is a real endeavor. Despite country- and continent-specific challenges, the Democratic Republic of the Congo (DRC) has been able to develop one of the most active PV systems in the sub-Saharan Africa. The World Health Organization (WHO) regional Office identified the DRC experience to set up a PV system for antimalarial drugs safety monitoring as a ‘best practice’ that needed to be documented in order to help DRC improve its PV system and to be scaled up in other African countries. In response to the WHO request, a best practices and bottlenecks analysis was conducted in 2015. This analysis was updated in 2018 in the light of the minimum requirements of the WHO to set up a PV system taking into account other guidance for PV systems. The following themes were retained for analysis: (1) creation of the national PV center; (2) implementation of PV in the health system; (3) data collection and analysis; (4) collaboration with public health programs; (5) collaboration with the National Regulatory Authority. Lessons learnt from the DRC experience show that it is possible to implement PV systems in order to promote patients’ safety in resource limited sub-Saharan African countries with no guaranteed funding. The ability of national PV centers to collaborate with Public health stakeholders, including public health authorities at all levels as well as public health programs, and to use existing health information systems are considered the main key to success and may substantially reduce the cost of PV activities. </jats:p> Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo Therapeutic Advances in Drug Safety |
| doi_str_mv |
10.1177/2042098619864853 |
| facet_avail |
Online Free |
| finc_class_facet |
Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8yMDQyMDk4NjE5ODY0ODUz |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8yMDQyMDk4NjE5ODY0ODUz |
| institution |
DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 |
| imprint |
SAGE Publications, 2019 |
| imprint_str_mv |
SAGE Publications, 2019 |
| issn |
2042-0986 2042-0994 |
| issn_str_mv |
2042-0986 2042-0994 |
| language |
English |
| mega_collection |
SAGE Publications (CrossRef) |
| match_str |
nzolo2019developmentofapharmacovigilancesysteminaresourcelimitedcountrytheexperienceofthedemocraticrepublicofcongo |
| publishDateSort |
2019 |
| publisher |
SAGE Publications |
| recordtype |
ai |
| record_format |
ai |
| series |
Therapeutic Advances in Drug Safety |
| source_id |
49 |
| title |
Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo |
| title_unstemmed |
Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo |
| title_full |
Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo |
| title_fullStr |
Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo |
| title_full_unstemmed |
Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo |
| title_short |
Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo |
| title_sort |
development of a pharmacovigilance system in a resource-limited country: the experience of the democratic republic of congo |
| topic |
Pharmacology (medical) |
| url |
http://dx.doi.org/10.1177/2042098619864853 |
| publishDate |
2019 |
| physical |
204209861986485 |
| description |
<jats:p> Implementation of pharmacovigilance (PV) systems in resource-limited countries is a real endeavor. Despite country- and continent-specific challenges, the Democratic Republic of the Congo (DRC) has been able to develop one of the most active PV systems in the sub-Saharan Africa. The World Health Organization (WHO) regional Office identified the DRC experience to set up a PV system for antimalarial drugs safety monitoring as a ‘best practice’ that needed to be documented in order to help DRC improve its PV system and to be scaled up in other African countries. In response to the WHO request, a best practices and bottlenecks analysis was conducted in 2015. This analysis was updated in 2018 in the light of the minimum requirements of the WHO to set up a PV system taking into account other guidance for PV systems. The following themes were retained for analysis: (1) creation of the national PV center; (2) implementation of PV in the health system; (3) data collection and analysis; (4) collaboration with public health programs; (5) collaboration with the National Regulatory Authority. Lessons learnt from the DRC experience show that it is possible to implement PV systems in order to promote patients’ safety in resource limited sub-Saharan African countries with no guaranteed funding. The ability of national PV centers to collaborate with Public health stakeholders, including public health authorities at all levels as well as public health programs, and to use existing health information systems are considered the main key to success and may substantially reduce the cost of PV activities. </jats:p> |
| container_start_page |
0 |
| container_title |
Therapeutic Advances in Drug Safety |
| container_volume |
10 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792343772794716166 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T16:57:00.941Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Development+of+a+pharmacovigilance+system+in+a+resource-limited+country%3A+the+experience+of+the+Democratic+Republic+of+Congo&rft.date=2019-01-01&genre=article&issn=2042-0994&volume=10&pages=204209861986485&jtitle=Therapeutic+Advances+in+Drug+Safety&atitle=Development+of+a+pharmacovigilance+system+in+a+resource-limited+country%3A+the+experience+of+the+Democratic+Republic+of+Congo&aulast=Tona&aufirst=Gaston&rft_id=info%3Adoi%2F10.1177%2F2042098619864853&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792343772794716166 |
| author | Nzolo, Didier, Kuemmerle, Andrea, Lula, Yves, Ntamabyaliro, Nsengi, Engo, Aline, Mvete, Bibiche, Liwono, Jerry, Lusakibanza, Mariano, Mesia, Gauthier, Burri, Christian, Mampunza, Samuel, Tona, Gaston |
| author_facet | Nzolo, Didier, Kuemmerle, Andrea, Lula, Yves, Ntamabyaliro, Nsengi, Engo, Aline, Mvete, Bibiche, Liwono, Jerry, Lusakibanza, Mariano, Mesia, Gauthier, Burri, Christian, Mampunza, Samuel, Tona, Gaston, Nzolo, Didier, Kuemmerle, Andrea, Lula, Yves, Ntamabyaliro, Nsengi, Engo, Aline, Mvete, Bibiche, Liwono, Jerry, Lusakibanza, Mariano, Mesia, Gauthier, Burri, Christian, Mampunza, Samuel, Tona, Gaston |
| author_sort | nzolo, didier |
| container_start_page | 0 |
| container_title | Therapeutic Advances in Drug Safety |
| container_volume | 10 |
| description | <jats:p> Implementation of pharmacovigilance (PV) systems in resource-limited countries is a real endeavor. Despite country- and continent-specific challenges, the Democratic Republic of the Congo (DRC) has been able to develop one of the most active PV systems in the sub-Saharan Africa. The World Health Organization (WHO) regional Office identified the DRC experience to set up a PV system for antimalarial drugs safety monitoring as a ‘best practice’ that needed to be documented in order to help DRC improve its PV system and to be scaled up in other African countries. In response to the WHO request, a best practices and bottlenecks analysis was conducted in 2015. This analysis was updated in 2018 in the light of the minimum requirements of the WHO to set up a PV system taking into account other guidance for PV systems. The following themes were retained for analysis: (1) creation of the national PV center; (2) implementation of PV in the health system; (3) data collection and analysis; (4) collaboration with public health programs; (5) collaboration with the National Regulatory Authority. Lessons learnt from the DRC experience show that it is possible to implement PV systems in order to promote patients’ safety in resource limited sub-Saharan African countries with no guaranteed funding. The ability of national PV centers to collaborate with Public health stakeholders, including public health authorities at all levels as well as public health programs, and to use existing health information systems are considered the main key to success and may substantially reduce the cost of PV activities. </jats:p> |
| doi_str_mv | 10.1177/2042098619864853 |
| facet_avail | Online, Free |
| finc_class_facet | Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8yMDQyMDk4NjE5ODY0ODUz |
| imprint | SAGE Publications, 2019 |
| imprint_str_mv | SAGE Publications, 2019 |
| institution | DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3 |
| issn | 2042-0986, 2042-0994 |
| issn_str_mv | 2042-0986, 2042-0994 |
| language | English |
| last_indexed | 2024-03-01T16:57:00.941Z |
| match_str | nzolo2019developmentofapharmacovigilancesysteminaresourcelimitedcountrytheexperienceofthedemocraticrepublicofcongo |
| mega_collection | SAGE Publications (CrossRef) |
| physical | 204209861986485 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | SAGE Publications |
| record_format | ai |
| recordtype | ai |
| series | Therapeutic Advances in Drug Safety |
| source_id | 49 |
| spelling | Nzolo, Didier Kuemmerle, Andrea Lula, Yves Ntamabyaliro, Nsengi Engo, Aline Mvete, Bibiche Liwono, Jerry Lusakibanza, Mariano Mesia, Gauthier Burri, Christian Mampunza, Samuel Tona, Gaston 2042-0986 2042-0994 SAGE Publications Pharmacology (medical) http://dx.doi.org/10.1177/2042098619864853 <jats:p> Implementation of pharmacovigilance (PV) systems in resource-limited countries is a real endeavor. Despite country- and continent-specific challenges, the Democratic Republic of the Congo (DRC) has been able to develop one of the most active PV systems in the sub-Saharan Africa. The World Health Organization (WHO) regional Office identified the DRC experience to set up a PV system for antimalarial drugs safety monitoring as a ‘best practice’ that needed to be documented in order to help DRC improve its PV system and to be scaled up in other African countries. In response to the WHO request, a best practices and bottlenecks analysis was conducted in 2015. This analysis was updated in 2018 in the light of the minimum requirements of the WHO to set up a PV system taking into account other guidance for PV systems. The following themes were retained for analysis: (1) creation of the national PV center; (2) implementation of PV in the health system; (3) data collection and analysis; (4) collaboration with public health programs; (5) collaboration with the National Regulatory Authority. Lessons learnt from the DRC experience show that it is possible to implement PV systems in order to promote patients’ safety in resource limited sub-Saharan African countries with no guaranteed funding. The ability of national PV centers to collaborate with Public health stakeholders, including public health authorities at all levels as well as public health programs, and to use existing health information systems are considered the main key to success and may substantially reduce the cost of PV activities. </jats:p> Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo Therapeutic Advances in Drug Safety |
| spellingShingle | Nzolo, Didier, Kuemmerle, Andrea, Lula, Yves, Ntamabyaliro, Nsengi, Engo, Aline, Mvete, Bibiche, Liwono, Jerry, Lusakibanza, Mariano, Mesia, Gauthier, Burri, Christian, Mampunza, Samuel, Tona, Gaston, Therapeutic Advances in Drug Safety, Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo, Pharmacology (medical) |
| title | Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo |
| title_full | Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo |
| title_fullStr | Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo |
| title_full_unstemmed | Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo |
| title_short | Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo |
| title_sort | development of a pharmacovigilance system in a resource-limited country: the experience of the democratic republic of congo |
| title_unstemmed | Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo |
| topic | Pharmacology (medical) |
| url | http://dx.doi.org/10.1177/2042098619864853 |